Cardiac surgery in patients with trisomy 18

Yukihiro Kaneko1, Jotaro Kobayashi, Ikuya Achiwa

  • 1Department of Cardiovascular Surgery, Japanese Red Cross Medical Center, Tokyo, Japan. yukihirokaneko@hotmail.com

Pediatric Cardiology
|April 3, 2009
PubMed

Insights

Cardiac surgery can effectively treat congenital heart defects in trisomy 18 patients, improving symptoms and survival. Palliative procedures showed better long-term outcomes than primary intracardiac repair for these complex cases.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Genetics

Background:

  • Trisomy 18 (Edwards syndrome) is a genetic disorder associated with severe congenital anomalies.
  • Congenital heart defects are common in trisomy 18, often leading to significant morbidity and mortality.
  • Cardiac surgery for trisomy 18 is infrequently performed but increasingly considered.

Purpose of the Study:

  • To report the clinical details and outcomes of cardiac surgery in patients with trisomy 18.
  • To evaluate the effectiveness of different surgical approaches (palliative vs. primary repair) in this population.
  • To assess postoperative survival and identify factors influencing outcomes.

Main Methods:

  • Retrospective review of 17 trisomy 18 patients who underwent cardiac surgery.
  • Analysis of patient demographics, cardiac defect types, surgical procedures (palliative or primary repair), and postoperative outcomes.
  • Comparison of survival rates between palliative surgery and primary intracardiac repair groups.

Main Results:

  • Seventeen patients underwent surgery at a median age of 66 days.
  • Common defects included ventricular septal defects, coarctation of the aorta, and patent ductus arteriosus.
  • 82% of patients were discharged with improved symptoms; median survival was 179 days.
  • Palliative surgery resulted in significantly better postoperative survival (median 257 days) compared to primary repair (median 48 days).

Conclusions:

  • Cardiac surgery can be effective in managing serious cardiac symptoms in trisomy 18 patients.
  • Palliative surgical strategies appear to offer better survival outcomes than primary intracardiac repair in this cohort.
  • Further research is needed to optimize surgical management for trisomy 18 patients with congenital heart disease.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...